Jonathan Violin
Chief Executive Officer at Viridian Therapeutics Inc.
Sits on 4 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 4 boards, counting each seat separately. Longest: Viridian Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Dianthus Therapeutics Inc. May 21, 202699.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 2, 2023 | Viridian Therapeutics Inc. | Open-market sale | −50,000 | $36.80 | $1,840,000 |
Questions about Jonathan Violin
What boards is Jonathan Violin on?
Jonathan Violin sits on the boards of Crescent Biopharma Inc., Dianthus Therapeutics Inc., Korsana Biosciences Inc. and Viridian Therapeutics Inc.
Has Jonathan Violin been a CEO?
Yes — Jonathan Violin was CEO of Viridian Therapeutics Inc. (Until October 2023).
How long has Jonathan Violin served on boards?
Our records show at least 9 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.